The global CAR T-cell therapy market is experiencing substantial growth, driven by increasing demand for cutting-edge cancer treatment options. This accelerated expansion is fueled by elements such as the acceptance of CAR T-cell therapies for diverse indications, advancements in engineering technologies, and expanding research and development prog